Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea

Annals of Hematology

Volumn 91, Issue 9, 2012, Pages 1403-1412

  Koh, Young Wha ^a   Yoon, Dok Hyun ^a   Suh, Cheolwon ^a   Huh, Jooryung ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Epstein Barr virus; Hodgkin lymphoma; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; PREDNISOLONE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER STAGING; CHEMORADIOTHERAPY; CHILD; COHORT ANALYSIS; DISEASE SPECIFIC SURVIVAL; EPSTEIN BARR VIRUS INFECTION; EVENT FREE SURVIVAL; FEMALE; GENDER; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SOUTH KOREA; TUMOR CELL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; EPSTEIN-BARR VIRUS INFECTIONS; FOLLOW-UP STUDIES; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HOSPITALS, UNIVERSITY; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PROGNOSIS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RNA, VIRAL; SINGLE-BLIND METHOD; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864912851     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1464-8     Document Type: Article

References (39)

1. Parkin DM (2005) Cancer incidence in five continents, vols I-VIII. IARC Press, Lyon
2. Kuppers R (2009) The biology of Hodgkin's lymphoma. Nat Rev Cancer 9(1):15-27
3. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V (2009) A review of human carcinogens-Part B: biological agents. Lancet Oncol 10(4):321-322
4. Wu TC, Mann RB, Charache P, Hayward SD, Staal S, Lambe BC, Ambinder RF (1990) Detection of EBV gene expression in Reed- Sternberg cells of Hodgkin's disease. Int J Cancer 46(5):801-804
5. Weiss LM, Chen YY, Liu XF, Shibata D (1991) Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 139(6):1259-1265
6. Herbst H, Steinbrecher E, Niedobitek G, Young LS, Brooks L, Muller-Lantzsch N, Stein H (1992) Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease. Blood 80 (2):484-491
7. Hummel M, Anagnostopoulos I, Dallenbach F, Korbjuhn P, Dimmler C, Stein H (1992) EBV infection patterns in Hodgkin's disease and normal lymphoid tissue: expression and cellular localization of EBV gene products. Br J Haematol 82(4):689-694
8. Chang KL, Albujar PF, Chen YY, Johnson RM, Weiss LM (1993) High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru. Blood 81(2):496-501
9. Weinreb M, Day PJ, Niggli F, Green EK, Nyong'o AO, Othieno- Abinya NA, Riyat MS, Raafat F, Mann JR (1996) The consistent association between Epstein-Barr virus and Hodgkin's disease in children in Kenya. Blood 87(9):3828-3836
10. Fellbaum C, Hansmann ML, Niedermeyer H, Kraus I, Alavaikko MJ, Blanco G, Aine R, Busch R, Putz B, Fischer R (1992) Influence of Epstein-Barr virus genomes on patient survival in Hodgkin's disease. Am J Clin Pathol 98(3):319-323
11. Vestlev PM, Pallesen G, Sandvej K, Hamilton-Dutoit SJ, Bendtzen SM (1992) Prognosis of Hodgkin's disease is not influenced by Epstein-Barr virus latent membrane protein. Int J Cancer 50 (4):670-671
12. Morente MM, Piris MA, Abraira V, Acevedo A, Aguilera B, Bellas C, Fraga M, Garcia-Del-Moral R, Gomez-Marcos F, Menarguez J, Oliva H, Sanchez-Beato M, Montalban C (1997) Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression. Blood 90(6):2429-2436
13. Montalban C, Abraira V, Morente M, Acevedo A, Aguilera B, Bellas C, Fraga M, Del Moral RG, Menarguez J, Oliva H, Sanchez-Beato M, Piris MA (2000) Epstein-Barr virus-latent membrane protein 1 expression has a favorable influence in the outcome of patients with Hodgkin's disease treated with chemotherapy. Leuk Lymphoma 39(5-6):563-572
14. Naresh KN, Johnson J, Srinivas V, Soman CS, Saikia T, Advani SH, Badwe RA, Dinshaw KA, Muckaden M, Magrath I, Bhatia K (2000) Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells. Ann Oncol 11(1):91-96
15. Flavell KJ, Billingham LJ, Biddulph JP, Gray L, Flavell JR, Constandinou CM, Young LS, Murray PG (2003) The effect of Epstein-Barr virus status on outcome in age- and sexdefined subgroups of patients with advanced Hodgkin's disease. Ann Oncol 14(2):282-290
16. Clarke CA, Glaser SL, Dorfman RF, Mann R, DiGiuseppe JA, Prehn AW, Ambinder RF (2001) Epstein-Barr virus and survival after Hodgkin disease in a population-based series of women. Cancer 91(8):1579-1587
17. Stark GL, Wood KM, Jack F, Angus B, Proctor SJ, Taylor PR (2002) Hodgkin's disease in the elderly: a population-based study. Br J Haematol 119(2):432-440
18. Keegan TH, Glaser SL, Clarke CA, Gulley ML, Craig FE, Digiuseppe JA, Dorfman RF, Mann RB, Ambinder RF (2005) Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study. J Clin Oncol 23(30):7604-7613
19. Jarrett RF, Stark GL, White J, Angus B, Alexander FE, Krajewski AS, Freeland J, Taylor GM, Taylor PR (2005) Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study. Blood 106(7):2444-2451. doi:10.1182/blood-2004-09-3759
20. Chan JK, Yip TT, Tsang WY, Lau WH, Wong CS, Ma VW (1995) Detection of Epstein-Barr virus in Hodgkin's disease occurring in an Oriental population. Hum Pathol 26(3):314-318
21. Huh J, Park C, Juhng S, Kim CE, Poppema S, Kim C (1996) A pathologic study of Hodgkin's disease in Korea and its association with Epstein-Barr virus infection. Cancer 77(5):949-955
22. Tomita Y, Ohsawa M, Kanno H, Hashimoto M, Ohnishi A, Nakanishi H, Aozasa K (1996) Epstein-Barr virus in Hodgkin's disease patients in Japan. Cancer 77(1):186-192
23. Liu SM, Chow KC, Chiu CF, Tzeng CH (1998) Expression of Epstein-Barr virus in patients with Hodgkin's disease in Taiwan. Cancer 83(2):367-371
24. Huang X, Nolte I, Gao Z, Vos H, Hepkema B, Poppema S, van den Berg A, Diepstra A (2011) Epidemiology of classical Hodgkin lymphoma and its association with Epstein-Barr virus in Northern China. PLoS One 6 (6):e21152. doi:10.1371/journal.pone.0021152
25. Kwon JM, Park YH, Kang JH, Kim K, Ko YH, Ryoo BY, Lee SS, Lee SI, Koo HH, Kim WS (2006) The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma. Ann Hematol 85 (7):463-468. doi:10.1007/s00277-006-0081-9
26. Vassilakopoulos TP, Angelopoulou MK, Siakantaris MP, Kontopidou FN, Dimopoulou MN, Barbounis A, Grigorakis V, Karkantaris C, Anargyrou K, Chatziioannou M, Rombos J, Boussiotis VA, Vaiopoulos G, Kittas C, Pangalis GA (2002) Prognostic factors in advanced stage Hodgkin's lymphoma: the significance of the number of involved anatomic sites. Eur J Haematol 67(5-6):279-288
27. Glavina-Durdov M, Jakic-Razumovic J, Capkun V, Murray P (2001) Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease. Br J Cancer 84(9):1227-1234
28. Enblad G, Sandvej K, Lennette E, Sundstrom C, Klein G, Glimelius B, Pallesen G (1997) Lack of correlation between EBV serology and presence of EBVin theHodgkin and Reed-Sternberg cells of patients with Hodgkin's disease. Int J Cancer 72(3):394-397
29. Enblad G, Sandvej K, Sundstrom C, Pallesen G, Glimelius B (1999) Epstein-Barr virus distribution in Hodgkin's disease in an unselected Swedish population. Acta Oncol 38(4):425-429
30. Herling M, Rassidakis GZ, Medeiros LJ, Vassilakopoulos TP, Kliche KO, Nadali G, Viviani S, Bonfante V, Giardini R, Chilosi M, Kittas C, Gianni AM, Bonadonna G, Pizzolo G, Pangalis GA, Cabanillas F, Sarris AH (2003) Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome. Clin Cancer Res 9(6):2114-2120
31. Krugmann J, Tzankov A, Gschwendtner A, Fischhofer M, Greil R, Fend F, Dirnhofer S (2003) Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study. Mod Pathol 16(6):566-573
32. Diepstra A, van Imhoff GW, Schaapveld M, Karim-Kos H, van den Berg A, Vellenga E, Poppema S (2009) Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients. J Clin Oncol 27 (23):3815-3821
33. Chang KC, Chen PC, Jones D, Su IJ (2008) Changing patterns in the frequency of Hodgkin lymphoma subtypes and Epstein-Barr virus association in Taiwan. Cancer Sci 99(2):345-349
34. Engel M, Essop MF, Close P, Hartley P, Pallesen G, Sinclair-Smith C (2000) Improved prognosis of Epstein-Barr virus associated childhood Hodgkin's lymphoma: study of 47 South African cases. J Clin Pathol 53(3):182-186
35. Claviez A, Tiemann M, Luders H, Krams M, Parwaresch R, Schellong G, Dorffel W (2005) Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma. J Clin Oncol 23(18):4048-4056. doi:10.1200/JCO.2005.01.70136
36. Haynes L, Maue AC (2009) Effects of aging on T cell function. Curr Opin Immunol 21(4):414-417
37. Panda A, Arjona A, Sapey E, Bai F, Fikrig E, Montgomery RR, Lord JM, Shaw AC (2009) Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol 30(7):325-333
38. Khan G, Lake A, Shield L, Freeland J, Andrew L, Alexander FE, Jackson R, Taylor PR, McCruden EA, Jarrett RF (2005) Phenotype and frequency of Epstein-Barr virus-infected cells in pretreatment blood samples from patients with Hodgkin lymphoma. Br J Haematol 129(4):511-519
39. Gandhi MK, Tellam JT, Khanna R (2004) Epstein-Barr virusassociated Hodgkin's lymphoma. Br J Haematol 125(3):267-281